BMC Public Health 2007, 7:348 http://www.biomedcentral.com/1471-2458/7/348 13. Vogt MT, McKenna M, Anderson SJ, Wolfson SK, Kuller LH: The relationship between ankle-arm index and mortality in older men and women. J Am Geriatr Soc 1993, 41:523-30. 14. Tolonen H, Mahonen M, Asplund K, Rastenyte D, Kuulasmaa K, Vanuzzo D, Tuomilehto J: Do trends in population levels of blood pressure and other cardiovascular risk factors explain trends in stroke event rates? Comparisons of 15 populations in 9 countries within the WHO MONICA Stroke Project. World Health Organization Monitoring of Trends andDeter- minants in Cardiovascular Disease. Stroke 2002, 33:2367-75. 15. Hooi JD, Kester AD, Stoffers HE, Rinkens PE, Knottnerus JA, vanRee JW: Asymptomatic peripheral arterial occlusive disease pre- dicted cardiovascular morbidity and mortality in a 7-year fol- low-up study. J Clin Epidemiol 2004, 57:294-300. 16. Resnick HE, Lindsay RS, McDermott MM, Devereux RB, Jones KL, Fabsitz RR, Howard BVl: Relationship of high and low ankle bra- chial index to all-cause and cardiovascular disease mortality: the Strong Heart Study. Circulation 2004, 109:733-9. 17. Doobay AV, Anand SS: Sensitivity and specificity of the ankle- brachial index to predict future cardiovascular outcomes: a systematic review. Arterioscler Thromb Vasc Biol 2005, 25:1463-9. 18. Hooi JD, Stoffers HE, Knottnerus JA, van Ree JW: The prognosis of non-critical limb ischaemia: a systematic review of popula- tion-based evidence. Br J Gen Pract 1999, 49:49-55. 19. Hooi JD, Stoffers HE, Kester AD, Rinkens PE, Kaiser V, van ReeJW, Knottnerus JA: Risk factors and cardiovascular diseases associ- ated with asymptomatic peripheral arterial occlusive dis- ease. The Limburg PAOD Study. Peripheral Arterial Occlusive Disease. Scand J Prim Health Care 1998, 16:177-82. 20. Bundo M, Auba J, Valles R, Torner O, Perez AM, Massons J: Arteri- opatía periférica en la diabetes mellitus tipo 2. Aten Primaria 1998, 22:5-11. 21. Norman PE, Eikelboom JW, Hankey GJ: Peripheral arterial dis- ease: prognostic significance and prevention of athero- thrombotic complications. Med J Aust 2004, 181:150-4. 22. Hollander M, Bots ML, Del Sol AI, Koudstaal PJ, Witteman JC, Grob- bee DE, Hofman A, Breteler MM: Carotid plaques increase the risk of stroke and subtypes of cerebral infarction in asympto- matic elderly: the Rotterdam study. Circulation 2002, 105:2872-7. 23. Planas A, Clara A, Marrugat J, Pou JM, Gasol A, de Moner A: Age at onset of smoking is an independent risk factor in peripheral artery disease development. J Vasc Surg 2002, 35:506-9. 24. Kweon SS, Shin MH, Park KS, Nam HS, Jeong SK, Ryu SY, Chung EK, Choi JS: Distribution of the ankle-brachial index and associ- ated cardiovascular risk factors in a population of middle- aged and elderly koreans. J Korean Med Sci 2005, 20:373-8. 25. Baena Diez JM, del Val Garcia JL, Tomas Pelegrina J, Martinez Martinez JL, Martin Penacoba R, González Tejon I: Epidemiología de las enfermedades cardiovasculares y factores de riesgo en aten- ción primaria. Rev Esp Cardiol 2005, 58:367-73. 26. Lahoz C, Vicente I, Laguna F, Garcia-Iglesias MF, Taboada M, Mostaza JM: Metabolic syndrome and asymptomatic peripheral artery disease in subjects over 60 years of age. Diabetes Care 2006, 29:148-150. 27. Vicente I, Lahoz C, Taboada M, Garcia A, San Martin MA, Terol I, Laguna F, Garcia-Iglesias F, Mostaza JM: Prevalencia de un índice tobillo-brazo patológico según el riesgo cardiovascular cal- culado mediante la función de Framingham. Med Clin (Barc) 2005, 124:641-644. 28. Lahoz C, Vicente I, Laguna F, Garcia-Iglesias MF, Taboada M, Mostaza JM: Metabolic syndrome and asymptomatic peripheral artery disease in subjects over 60 years of age. Diabetes Care 2006, 29:148-150. 29. Lahoz C, Vicente I, Taboada M, Laguna Fy, Mostaza JM: Índice tobillo-brazo y riesgo cardiovascular estimado mediante la función SCORE en sujetos no diabéticos en prevención pri- maria. Clin Invest Arterioscl 2006, 18:45-50. 30. Lahoz C, Mostaza JM: Ankle-brachial index: a useful tool for stratifying cardiovascular risk. Rev Esp Cardiol 2006, 59:647-9. 31. Vicente I, Lahoz C: Ankle-brachial index in patients with diabe- tes mellitus: prevalence and risk factors. Rev Clin Esp 2006, 206:225-9. 32. Manzano L, García-Díaz JD, Gómez-Cerezo J, Mateos J, del Valle FJ, Medina-Asensio J, Viejo LF, Fernández-Ballesteros A, Solís J, Herrero Domingo A, et al.: Manzano et al. Valor de la determinación del índice tobillo-brazo en pacientes de riesgo vascular sin enfermedad aterotrombótica conocida: estudio VITAMIN. Rev Esp Cardiol 2006, 59:662-670. 33. Bundo M, Pérez C, Montero JJ, Cobos MD, Aubà J, Cabezas C: Arte- riopatía periférica de extremidades inferiores y morbimor- talidad en pacientes diabéticos tipo 2. Atención Primaria 2006, 38:139-46. 34. Lahoz C, Vicente I, Taboada M, Laguna Fy, Mostaza JM: índice tobillo-brazo y riesgo cardiovascular estimado mediante la funciónSCORE en sujetos no diabéticos en prevención pri- maria. Clin Invest Arterioscl 2006, 18:45-50. 35. Kjellstrom T, Norrving B, Shatchkute A: HelsingborgDeclaration 2006 on European stroke strategies. Cerebrovasc Dis 2007, 23:231-41. 36. Kesaniemi YA, Danforth E Jr, Jensen MD, Kopelman PG, Lefebvre P, Reeder BA: Dose-response issues concerning physical activity and health: an evidence-based symposium. Med Sci Sports Exerc 2001, 33:S351-8. 37. Cryer PE: Management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabe- tes Association and the European Association for the Study of Diabetes. Diabetes Care 2007, 30:190-2. 38. Villar Alvarez F, Maiques Galán A, Brotons Cuixart C, Torcal Laguna J, Lorenzo Piqueres A, Vilaseca Canals J, Banegas Banegas JR, RodríguezArtalejo F, Gil Guillén V: Preventive cardiovascular recommendations: practical applications of cardiovascular risk. Group for Cardiovascular Prevention of the PAPPS. Aten Primaria 1999, 24(Suppl 1):66-75. 39. Kannel WB: Heart Fail Rev 1999, 5(2):167-73. 40. Wilson PWF, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB: Prediction of coronary heart disease using risk factor categories. Circulation 1998, 97:1837-47. 41. Senti M, Masia R, Pena A, Elosua R, Aubo C, Bosch M, Sala J, Marrugat J: Determinantes antropométricos y dietéticos de la concen- tración sérica del colesterol de las lipoproteínas de alta den- sidad en un estudio de base poblacional. El estudio REGICOR. Rev Esp Cardiol 1998, 51:979-87. 42. Neuhauser HK, Ellert U, Kurth BM: A comparison of Framing- ham and SCORE-based cardiovascular risk estimates in par- ticipants of the German National Health Interview and Examination Survey 1998. Eur J Cardiovasc Prev Rehabil 2005, 12:442-50. 43. Andersen AH, Hvidberg E: New classification of drugs: ATC- code introduced. Sygeplejersken 81:24-6. 1981 Oct 7 44. Hvidberg E, Andersen AH: New classification of drugs. TheMed- ical list and the Drug catalogue are introduced in Anatomi- cal-Therapeutic-Chemical classification code (ACT-code) in 1981. Ugeskr Laeger 142(6):396-7. 1980 Feb 4 45. Housley E, Leng GC, Donnan PT, Fowkes FG: Physical activity and risk of peripheral arterial disease in the general population: Edinburgh Artery Study. J Epidemiol Community Health 1993, 47:475-80. 46. Kaiser V, Kester AD, Stoffers HE, Kitslaar PJ, Knottnerus JA: The influence of experience on the reproducibility of the ankle- brachial systolic pressure ratio in peripheral arterial occlu- sive disease. Eur J Vasc Endovasc Surg 1999, 18:25-9. Pre-publication history The pre-publication history for this paper can be accessed here: http://www.biomedcentral.com/1471-2458/7/348/pre pub Page 7 of 7 (page number not for citation purposes)